Last updated: April 25, 2026
What is LODOSYN and how is it sourced?
LODOSYN is the brand name for levodopa tablets marketed with carbidopa-free labeling. In the U.S., “LODOSYN” is not a raw API commodity with a single universal supplier; it is a finished-dose product that can be manufactured and supplied by one or more contract manufacturers and/or label holders depending on package size, marketing status, and regulatory availability.
What suppliers can be identified from authoritative product records?
No complete, supplier-level answer can be produced from the information provided. The question requires a mapping from “LODOSYN” to:
- Finished product labeler/marketer
- Manufacturing site(s) / contract manufacturer(s)
- Drug substance (levodopa) API suppliers (if requested)
Those supplier details are typically found in FDA labeling, Orange Book/Drug Registration and Listing (DRLS), and facility inspection records. In the absence of those records in the prompt, a correct supplier list cannot be generated.
Why a supplier list cannot be stated from the prompt alone
A supplier response must cite specific entities (company names and roles) tied to LODOSYN’s regulatory and manufacturing record. Without those records, any list of suppliers would be speculative and would not meet a patent/market intelligence standard.
Key Takeaways
- LODOSYN supply is not a single known supplier in the absence of FDA regulatory record extraction.
- A valid “suppliers” answer must be grounded in FDA product listing/manufacturing records and cannot be derived from the prompt alone.
FAQs
-
Is LODOSYN manufactured by one company or multiple?
It can be supplied through multiple manufacturing arrangements across product presentations, but the specific entities must be pulled from FDA listings.
-
Do “suppliers” mean API manufacturers or finished-dose manufacturers?
Supplier mapping depends on the intended scope. Finished-dose manufacturers and API suppliers are different roles.
-
Where are reliable supplier details stored for branded products like LODOSYN?
In FDA product listing and labeling records, typically tied to manufacturing sites.
-
Can a supplier list be confirmed without FDA database lookups?
Not to a standard suitable for investment or R&D sourcing decisions.
-
Does LODOSYN availability affect who supplies it?
Yes. Marketing and manufacturing can change with supply continuity, contract transitions, and product lifecycle events.
References
[1] FDA. Orange Book / Drug Products (levodopa) and product listing records.
[2] FDA. Drug Registration and Listing (DRLS) database for LODOSYN labeler/manufacturer attribution.
[3] FDA. SPL (Structured Product Labeling) for LODOSYN product labeling and manufacturer sections.
